Skip directly to content

Investigator eligibility for submission

Investigator eligibility and participating countries

  • You are an MD, PhD or PharmD.
  • You are affiliated with an academic or medical institution (e.g. hospital, university).
  • You and your institution are based in one of the eligible countries listed below.
  • Your research will be conducted in accordance with local regulatory, legal, and ethical guidelines, including posting on a clinical trial registry where appropriate. Pfizer/BMS assumes no responsibility for the conduct of the selected studies
  • The maximum amount of funding requested for your project is no more than €300,000.
  • You are able to start the study within 6 months after contracting and complete it within 2 years.
  • Your research output would merit submission as an abstract to scientific meetings and subsequent publication in a peer-reviewed journal.
  • You are not receiving funding from other pharmaceutical companies for the research proposal that is being submitted.

If additional guidance on your submission is needed please contact your local medical team

Eligible countries

Applicants will be directed to either the BMS or Pfizer website to register and submit their applications. This is due to the division of responsibilities between the two companies, Pfizer and BMS, for handling investigator-initiated research.

Global BMS ISR portal

Applicants from the following countries will be directed to the BMS website

AustriaUnited Kingdom
AustraliaBelgium
DenmarkFinland
FranceGermany
IcelandIreland
ItalyLiechtenstein
LuxembourgMalta
NetherlandsNorway
PortugalSouth Korea
SwedenSpain
Switzerland
Global BMS ISR portal

 

Applicants from the following countries will be directed to the BMS website which can be accessed via the BMS portal after registration is completed.

AustriaUnited Kingdom
AustraliaBelgium
DenmarkFinland
FranceGermany
IcelandIreland
ItalyLiechtenstein
LuxembourgMalta
NetherlandsNorway
PortugalSpain
SwedenSwitzerland
Pfizer IIR portal

Applicants from the following countries will be directed to the Pfizer website

AlbaniaIsraelRomania
Bosnia HerzegovinaKazakhstanRussia
BulgariaKosovoSerbia
CroatiaLatviaSlovakia
Czech RepublicLithuaniaSlovenia
EstoniaMacedoniaTurkey
GeorgiaMontenegroUkraine
GreecePoland
HungaryRepublic of Cyprus

Pfizer IIR portal

 

Applicants from the following countries will be directed to the Pfizer Investigator Initiated Research (INSPIIRE) portal. Create an account and submit your proposed designated Concept Summary Form, which can be accessed after creating your account.

AlbaniaBosnia Herzegovina
BulgariaCroatia
Czech RepublicEstonia
GeorgiaGreece
HungaryIsrael
KazakhstanKosovo
LatviaLithuania
MacedoniaMontenegro
PolandRepublic of Cyprus
RomaniaRussia
SerbiaSlovakia
SloveniaTurkey
Ukraine

This site is intended for the use of investigators considering a submission or intending to submit to the ERISTA program. It is NOT intended to provide product information.